Open AccessPredictors of outcome for EGFR-mutant non-small-cell lung cancer treated with first-line tyrosine kinase inhibitors
Author(s) -
Sara Pilotto,
Emilio Bria
Publication year - 2013
Publication title -
lung cancer management
Language(s) - English
Resource type - Journals
eISSN - 1758-1974
pISSN - 1758-1966
DOI - 10.2217/lmt.12.57
Subject(s) - tyrosine kinase , lung cancer , mutant , medicine , cancer research , oncology , t790m , osimertinib , kinase , cancer , erlotinib , biology , epidermal growth factor receptor , gefitinib , receptor , microbiology and biotechnology , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom